Skip to main navigation

+1 (206) 588-0256
Privacy Policy

Menu

About Us
- Leadership Team
- Our Culture
Development Pipeline
- Breast Cancer Program
Investors
Contact Us

About Us
- Leadership Team
- Our Culture
Development Pipeline
- Breast Cancer Program
Investors
Contact Us

Glossary

Overview
Stock Info
Stock Quote & Chart Historical Price Lookup Investment Calculator Analyst Coverage
News & Events
News Releases Events & Presentations
Financials & Filings
SEC Filings Quarterly Results Annual Reports Financial Fundamentals
Corporate Governance
Governance Documents Leadership Team Board of Directors Committee Composition
IR Resources
FAQs Email Alerts Contact IR

Gross Margin

Gross Margin represents Gross Profit divided by Revenue.

Atossa Therapeutics is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology. Atossa’s current focus is on breast cancer.

Company

About
Leadership Team
Development Pipeline
Breast Cancer Program
Lung Inhilation Therapy
Contact Us
Culture

Investor Relations

Overview
Stock Info
New & Events
Financials & Filings
Corporate Governance
IR Resources

Contact

1 (206) 588-0256
info@atossainc.com
10202 5th Ave NE, Suite 200
Seattle, WA 98125

Facebook Twitter Linkedin

Copyright © 2024 Atossa Therapeutics Inc. All Rights Reserved.

Privacy Policy | Legal | Terms of Use | Expanded Access Policy